GPX4 and Parkinson disease: Key regulators such as glutathione peroxidase 4 (GPX4), ferritin, and transferrin are dysregulated in PD, suggesting therapeutic potential for ferroptosis inhibitors and iron chelators (Wang et al., 2023; Xing et al., 2023).